The TPRD gene (tetratricopeptide (TPR) containing Down syndrome gene) is one of the candidate genes in the Down syndrome chromosomal region-1. Duplication of this gene may be the cause of major phenotypic features of Down syndrome. Here we show that the TPRD expression is developmentally regulated during human embryogenesis. At the earliest stages of development (Carnegie 8±12) TPRD expression is ubiquitous. At later developmental stages (Carnegie stages 14, 16 and 18), it becomes restricted to the nervous system, as is the case for the mtprd gene during mouse development. We extended our analysis of TPRD expression during fetal development of the human nervous system (13, 22 and 24 weeks). A new oblique illumination technique was used to compare signal intensity and cell density. Some regions of the nervous system such as the external cortical layers of the brain, and the inner neuroblastic layer of the eye, strongly express the TPRD gene. q
Results
Down syndrome (DS), or trisomy 21, results from the presence in all cells of an extra copy of chromosome 21. It is the most frequent genetic cause of mental retardation. Molecular studies of rare patients with partial trisomy 21 have led to the de®nition of the Down syndrome Chromosomal Region-1 (DCR-1). This region is associated with many features of Down syndrome, including cranio-facial defects, muscular abnormalities and mental retardation (Delabar et al., 1993) . Indeed, the overexpression of one or several of the genes in DCR-1 could be responsible for the main DS features. Transcriptional analysis of this 2.3 Mb region has revealed 27 potential transcriptional units and 11 genes (Dahmane et al., 1998) .
One of these candidate genes for DS, TPRD, has recently been identi®ed (Ohira et al., 1996; Tsukahara et al., 1996; Dahmane et al., 1998) , It has a mouse ortholog, mtprd (Tsukahara et al., 1998) and the encoded protein contains, in its N-terminal region, three units of a 34-amino acid repeat similar to a tetratricopeptide (TPR) motif (Sikorski et al., 1990) . Although the function of TPRD is unknown, TPR motifs are found in proteins involved in the regulation of RNA synthesis and mitosis (Goebl and Yanagida, 1991; Lamb et al., 1995) . These motifs are involved in proteinprotein interactions (Groves and Barford, 1999) .
The expression of the murine ortholog of TPRD, mtprd, is developmentally regulated (Lopes et al., 1999) . After E10, the expression is no longer ubiquitous: the gene is expressed only in some regions of the central nervous system. Here we extend this study to early human development. In particular, we studied TPRD expression by in situ hybridization from very early embryonic stages (18 post-ovulatory (p.o.) days) to late fetal stages (24 weeks).
We recently isolated two human TPRD cDNAs by cDNA selection (Dahmane et al., 1998) and generated antisense and sense probes, respectively, nt 1772±2819 and nt 8435±9009 from sequence D83077. Identical results were obtained using both probes.
TPRD mRNA was ubiquitous in very early embryos, at 18±26 p.o. days or Carnegie (C) stages 8±12. These stages correspond to the formation of the neural groove and the neural crest, and to the closure of the neuropores (Fig.  1A,B) . During the next 10 days, the signal increased in the nervous structures ( Fig. 1C) and, from the 16C stage, became stronger throughout the nervous system, including the forebrain, the midbrain, the hindbrain, the spinal cord and the root ganglia ( Fig. 1D ,E). At this stage, a lower and apparently ubiquitous signal persisted in all non-nervous tissues.
At 45 and 50 p.o. days ( Fig. 1F ,J), the strongest signal was found in the nervous system, particularly in the mantle zone and the intermediate zone of the neural tube, in the root Fig. 1 . TPRD expression pattern during human development. Developmental stages were estimated on anatomical criteria, according to the Carnegie staging system (O'Rahilly and Mu Èller, 1987) . Embryos were ®xed in formaldehyde, dehydrated and paraf®n embedded, and serial sections cut. Carnegie stages 8 (A),ganglia and in the dorsal roots. The expression level was lower in the ventricular zone of the neural tube, in the retina and the olfactory epithelium. The TPRD gene was also strongly expressed, although at a lower level, in the intervertebral disks and in some endothelial tissues (Fig. 1I,J) .
In the developing nervous system of fetuses, up to 24 (Oblique illumination: this technique allows oblique illumination, the property of which is that the resulting image appears as if the specimen were being viewed from an angle; this gives an impression of relief. This effect is created by slightly moving the bulb laterally and by using the position of the phase contrast condenser where the light ®eld is the largest. It is thus possible to distinguish between cell bodies and extracellular matrix without staining weeks (Figs. 1K, 2E±L and 3A±H ), the TPRD gene was expressed with regionally varying intensities. A strong TPRD mRNA signal was observed in the developing neocortex, in the cerebellar cortex and in several cerebral and cerebellar nuclei. In the future cerebral cortex, TPRD expression was strongest in the area of the mantle zone, at the end of the embryonic life (Fig. 2A±D) . During the fetal period, when the cells migrate to form cortical layers, the signal was stronger in more external cortical layers than in the internal layers (Fig.  2E±H) .
Using a new oblique illumination technique that we have developed recently (unpublished data), we found that the number of cells in the external layers is lower than that in the other layers, in particular in the ventricular layers (Fig.  2F,H) . Thus, the more intense signal in the external layers presumably re¯ects stronger expression of TPRD in these cells. In the external, Purkinje and granular cell layers of the cerebellum, all cells seemed to express the TPRD gene at the same level (Fig. 2I,J) . In the maturing spinal cord, the strongest expression was observed in the sensory neurons of the dorsal horns (Fig. 2K,L) . . Abbreviations: C, cornea; ci, capsula interna; GZ, germinative zone; inl, inner neuroblastic layer; IZ, intermediate zone; L, lens; nc, nucleus caudatus; ngc, nucleus giganto-cellularis; no, nucleus olivaris; nr, neural retina; nrm, nucleus raphus magnus; nvc, nucleus vestibulo-cochlear; onl, outer neuroblastic layer; P, pupil; pr, pigment retina. VE, IV ventricle; VIII, VIII cranian nerve; white asterisk, outer neuroblastic layer of the retina; black asterisk, inner neuroblastic layer of the retina. Arrows point to single neurons expressing the TPRD gene.
In some regions of the developing brain, expression was ubiquitous: all nuclei and zones, including the nucleus olivaris and the germinative zone were labeled (Fig. 3A±  D) . In other regions, for example the caudatus nucleus, the cranial nerve nuclei of the brain stem and the capsula interna, only some cells were positive (Fig. 3E±H) .
We also analyzed TPRD expression in a 22 week eye (Fig.  3I±L) . We found a strong signal in the neural retina, consisting of two cell layers (Fig. 3J,L) . A stronger mRNA signal was found in the inner neuroblastic layer, with a lower cell density, than in the outer neuroblastic layer (Fig. 3J±L) .
During the development of human and mouse the expression, ubiquitous in the early stages, becomes progressively restricted. In the later stages of human and mouse embryo development, the strongest expression is speci®cally restricted to non-proliferating zones containing differentiated neurons.
An altered cortical lamination is observed in DS patients. This process begins at 23 weeks gestation (Golden et al., 1994) . Therefore our observation of a very strong TPRD expression in the cortex and its evolution from 13 to 22 weeks gestation, when the size of the cortical mantle doubles in thickness (Fig. 2E±H) is of interest. In particular the signal, ®rst uniform in the cortical mantle at 13 weeks gestation, shows a speci®c increase in the apical zone at 22 weeks gestation, when the cortical lamination begins.
Methods

Human embryos and fetus
Human embryos at Carnegie stages 8, 10, 12, 14, 16 and 18, corresponding to 18±50 post-ovulatory days, and human fetus at 13, 22 and 24 weeks gestation, were obtained from legally approved medical abortions in the Necker Hospital feto-pathological laboratory. The project was carried out with the approval of the French National Ethics Committee.
Optical techniques
Sections were examined using a Nikon SMZ U for magni®cation 7.5±75£, and a LEICA DM RB for magni®cations 100±400£.
Hybridizations
They were performed as described in (Lopes et al., 1999) .
